# Pathward Financial, Inc.: financial statements, quarterly

CASH · Nasdaq · CIK 907471 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/cash.md) · [Financials](/companies/cash/financials.md) · [Filings](/companies/cash/filings.md) · [Insiders](/companies/cash/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cash/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [184 d](/filings/0000907471-25-000083.md) | [172](/filings/0000907471-25-000090.md) | [258](/filings/0000907471-25-000093.md) | [189](/filings/0000907471-25-000096.md) | [180 d](/filings/0000907471-25-000116.md) | [183](/filings/0000907471-26-000011.md) | [275](/filings/0000907471-26-000025.md) | [196](/filings/0000907471-26-000034.md) | [187 d](/filings/0000907471-25-000116.md) | [173](/filings/0000907471-26-000011.md) | [276](/filings/0000907471-26-000025.md) | [190](/filings/0000907471-26-000034.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000907471-26-000011.md) | [0.0](/filings/0000907471-26-000025.md) | [0.0](/filings/0000907471-26-000034.md) | [0.0 d](/filings/0000907471-25-000116.md) | [0.0](/filings/0000907471-26-000011.md) | [0.0](/filings/0000907471-26-000025.md) | [0.0](/filings/0000907471-26-000034.md) |
| Interest expense | $m | [4.7](/filings/0000907471-23-000138.md) | [5.9](/filings/0000907471-24-000009.md) | [8.5](/filings/0000907471-24-000071.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(4.8)](/filings/0000907471-25-000083.md) | [7.7](/filings/0000907471-25-000090.md) | [16.9](/filings/0000907471-25-000093.md) | [6.1](/filings/0000907471-25-000096.md) | [3.4](/filings/0000907471-25-000083.md) | [6.0](/filings/0000907471-26-000011.md) | [16.2](/filings/0000907471-26-000025.md) | [4.8](/filings/0000907471-26-000034.md) | [9.3 d](/filings/0000907471-25-000116.md) | [7.2](/filings/0000907471-26-000011.md) | [14.2](/filings/0000907471-26-000025.md) | [3.1](/filings/0000907471-26-000034.md) |
| Net income | $m | [25.3](/filings/0000907471-25-000116.md) | [34.9](/filings/0000907471-25-000116.md) | [69.9](/filings/0000907471-25-000116.md) | [44.9](/filings/0000907471-25-000116.md) | [33.5](/filings/0000907471-25-000116.md) | [30.0](/filings/0000907471-26-000011.md) | [75.0](/filings/0000907471-26-000025.md) | [42.1](/filings/0000907471-26-000034.md) | [38.8](/filings/0000907471-25-000116.md) | [35.2](/filings/0000907471-26-000011.md) | [72.9](/filings/0000907471-26-000025.md) | [29.0](/filings/0000907471-26-000034.md) |
| Diluted EPS | $ per share | [0.96](/filings/0000907471-25-000116.md) | [1.34](/filings/0000907471-25-000116.md) | [2.74](/filings/0000907471-25-000116.md) | [1.78](/filings/0000907471-25-000116.md) | [1.34](/filings/0000907471-25-000116.md) | [1.23](/filings/0000907471-26-000011.md) | [3.14](/filings/0000907471-26-000025.md) | [1.81](/filings/0000907471-26-000034.md) | [1.69](/filings/0000907471-25-000116.md) | [1.57](/filings/0000907471-26-000011.md) | [3.35](/filings/0000907471-26-000025.md) | [1.37](/filings/0000907471-26-000034.md) |
| Basic EPS | $ per share | [0.96](/filings/0000907471-25-000116.md) | [1.34](/filings/0000907471-25-000116.md) | [2.74](/filings/0000907471-25-000116.md) | [1.78](/filings/0000907471-25-000116.md) | [1.34](/filings/0000907471-25-000116.md) | [1.23](/filings/0000907471-26-000011.md) | [3.16](/filings/0000907471-26-000025.md) | [1.83](/filings/0000907471-26-000034.md) | [1.69](/filings/0000907471-25-000116.md) | [1.57](/filings/0000907471-26-000011.md) | [3.37](/filings/0000907471-26-000025.md) | [1.37](/filings/0000907471-26-000034.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [376](/filings/0000907471-25-000083.md) | [672](/filings/0000907471-25-000083.md) | [348](/filings/0000907471-25-000083.md) | [299](/filings/0000907471-25-000083.md) | [158](/filings/0000907471-25-000116.md) | [597](/filings/0000907471-25-000090.md) | [254](/filings/0000907471-25-000093.md) | [258](/filings/0000907471-25-000096.md) | [121](/filings/0000907471-26-000034.md) | [331](/filings/0000907471-26-000011.md) | [158](/filings/0000907471-26-000025.md) | [149](/filings/0000907471-26-000034.md) |
| Total assets | $m | [7,503](/filings/0000907471-25-000116.md) | [7,903](/filings/0000907471-25-000090.md) | [7,417](/filings/0000907471-25-000093.md) | [7,513](/filings/0000907471-25-000096.md) | [7,532](/filings/0000907471-25-000116.md) | [7,603](/filings/0000907471-26-000011.md) | [6,995](/filings/0000907471-26-000025.md) | [7,230](/filings/0000907471-26-000034.md) | [7,172](/filings/0000907471-26-000034.md) | [7,560](/filings/0000907471-26-000011.md) | [7,112](/filings/0000907471-26-000025.md) | [7,314](/filings/0000907471-26-000034.md) |
| Total liabilities | $m | [6,885](/filings/0000907471-25-000083.md) | [7,198](/filings/0000907471-25-000083.md) | [6,698](/filings/0000907471-25-000083.md) | [6,765](/filings/0000907471-25-000083.md) | [6,710](/filings/0000907471-25-000116.md) | [6,846](/filings/0000907471-25-000090.md) | [6,181](/filings/0000907471-25-000093.md) | [6,412](/filings/0000907471-25-000096.md) | [6,315](/filings/0000907471-26-000034.md) | [6,706](/filings/0000907471-26-000011.md) | [6,262](/filings/0000907471-26-000025.md) | [6,463](/filings/0000907471-26-000034.md) |
| Long-term debt | $m | [33.9](/filings/0000907471-25-000083.md) | [33.6](/filings/0000907471-25-000083.md) | [33.4](/filings/0000907471-25-000083.md) | [33.3](/filings/0000907471-25-000083.md) | [33.4](/filings/0000907471-25-000116.md) | [33.4](/filings/0000907471-25-000090.md) | [33.4](/filings/0000907471-25-000093.md) | [33.4](/filings/0000907471-25-000096.md) | [33.5](/filings/0000907471-26-000034.md) | [33.5](/filings/0000907471-26-000011.md) | [33.5](/filings/0000907471-26-000025.md) | [33.5](/filings/0000907471-26-000034.md) |
| Current portion of debt | $m | [13.0](/filings/0000907471-25-000083.md) | not reported | not reported | not reported | [377](/filings/0000907471-25-000116.md) | not reported | not reported | not reported | [9.0](/filings/0000907471-25-000116.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | [13.0](/filings/0000907471-25-000083.md) | [0.0](/filings/0000907471-25-000083.md) | [31.0](/filings/0000907471-25-000083.md) | [0.0](/filings/0000907471-25-000083.md) | [377](/filings/0000907471-25-000116.md) | [0.0](/filings/0000907471-25-000090.md) | [0.0](/filings/0000907471-25-000093.md) | [115](/filings/0000907471-25-000096.md) | [9.0](/filings/0000907471-26-000034.md) | [0.0](/filings/0000907471-26-000011.md) | [26.0](/filings/0000907471-26-000025.md) | [168](/filings/0000907471-26-000034.md) |
| Shareholders' equity | $m | [619](/filings/0000907471-25-000083.md) | [705](/filings/0000907471-25-000083.md) | [719](/filings/0000907471-25-000083.md) | [748](/filings/0000907471-25-000083.md) | [822](/filings/0000907471-25-000116.md) | [758](/filings/0000907471-25-000090.md) | [815](/filings/0000907471-25-000093.md) | [819](/filings/0000907471-25-000096.md) | [858](/filings/0000907471-26-000034.md) | [855](/filings/0000907471-26-000011.md) | [851](/filings/0000907471-26-000025.md) | [851](/filings/0000907471-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [121 d](/filings/0000907471-25-000116.md) | [29.5](/filings/0000907471-25-000090.md) | [203 d](/filings/0000907471-25-000093.md) | [113 d](/filings/0000907471-25-000096.md) | [143 d](/filings/0000907471-25-000116.md) | [(71.7)](/filings/0000907471-26-000011.md) | [188 d](/filings/0000907471-26-000025.md) | [30.4 d](/filings/0000907471-26-000034.md) | [304 d](/filings/0000907471-25-000116.md) | [108](/filings/0000907471-26-000011.md) | [233 d](/filings/0000907471-26-000025.md) | [52.0 d](/filings/0000907471-26-000034.md) |
| Capital expenditure | $m | [3.7 d](/filings/0000907471-25-000116.md) | [1.9](/filings/0000907471-25-000090.md) | [1.7 d](/filings/0000907471-25-000093.md) | [2.2 d](/filings/0000907471-25-000096.md) | [4.4 d](/filings/0000907471-25-000116.md) | [2.1](/filings/0000907471-26-000011.md) | [3.6 d](/filings/0000907471-26-000025.md) | [2.7 d](/filings/0000907471-26-000034.md) | [3.3 d](/filings/0000907471-25-000116.md) | [4.2](/filings/0000907471-26-000011.md) | [2.3 d](/filings/0000907471-26-000025.md) | [3.4 d](/filings/0000907471-26-000034.md) |
| Dividends paid | $m | [1.3 d](/filings/0000907471-25-000116.md) | [1.3](/filings/0000907471-25-000090.md) | [1.3 d](/filings/0000907471-25-000093.md) | [1.3 d](/filings/0000907471-25-000096.md) | [1.2 d](/filings/0000907471-25-000116.md) | [1.2](/filings/0000907471-26-000011.md) | [1.2 d](/filings/0000907471-26-000025.md) | [1.2 d](/filings/0000907471-26-000034.md) | [1.1 d](/filings/0000907471-25-000116.md) | [1.1](/filings/0000907471-26-000011.md) | [1.1 d](/filings/0000907471-26-000025.md) | [1.1 d](/filings/0000907471-26-000034.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.1](/filings/0000907471-24-000009.md) | [27.2](/filings/0000907471-24-000071.md) | [26.4](/filings/0000907471-24-000084.md) | [25.8](/filings/0000907471-25-000090.md) | [25.3](/filings/0000907471-25-000093.md) | [25.0](/filings/0000907471-25-000096.md) | [24.3](/filings/0000907471-26-000011.md) | [23.8](/filings/0000907471-26-000025.md) | [23.1](/filings/0000907471-26-000034.md) | [22.4](/filings/0000907471-26-000011.md) | [21.7](/filings/0000907471-26-000025.md) | [21.2](/filings/0000907471-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,773,362 at 2026-07-29, from the cover of the [10-Q filed 2026-08-06](/filings/0000907471-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.